|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income | ||
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Income from investments held in Trust Account | ||
| Change in fair value of derivative warrant liabilities | ||
| Financing cost - derivative warrant liabilities | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Accounts payable | ||
| Accounts payable - related party | ||
| Accrued expenses | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Cash deposited in Trust Account | ||
| Cash used in investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from working capital loan - related party | ||
| Proceeds received from initial public offering, gross | ||
| Proceeds from private placement | ||
| Offering costs paid | ||
| Net cash provided by financing activities | ||
| Net change in cash | ||
| Cash - beginning of the period | ||
| Cash - end of the period | ||
| Supplemental disclosure of noncash investing and financing activities: | ||
| Offering costs included in accrued expenses | ||
| Offering costs included in notes payable | ||
| Deferred underwriting commissions in connection with the initial public offering | ||
| Extinguishment of deferred underwriting commissions allocated to public shares |
Loading...
